Sakar Healthcare Limited

Sakar Healthcare Limited (SAKAR) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.

sakarhealthcare.com(opens the company website in a new tab)
Ask AI

Key metrics

Price as of 2026-09-02

Stock price
₹985.80
Market cap
2,195 Cr
Stock P/E
60.8
P/B
6.75

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricSept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026Jun 2026
Sales34 Cr37 Cr43 Cr41 Cr43 Cr43 Cr50 Cr53 Cr58 Cr70 Cr71 Cr73 Cr
Operating expenses (approx.)25 Cr28 Cr32 Cr30 Cr31 Cr32 Cr35 Cr40 Cr46 Cr52 Cr45 Cr52 Cr
EBITDA9 Cr9 Cr11 Cr11 Cr12 Cr12 Cr16 Cr13 Cr11 Cr19 Cr26 Cr21 Cr
OPM %27.5%24.2%25.5%26.0%26.9%27.1%31.3%24.1%19.7%26.4%36.9%29.1%
Other income0.66 Cr0.23 Cr0.77 Cr0.46 Cr0.37 Cr0.30 Cr0.18 Cr0.39 Cr1 Cr0.51 Cr0.17 Cr2 Cr
Interest2 Cr2 Cr2 Cr1 Cr2 Cr1 Cr4 Cr2 Cr2 Cr2 Cr2 Cr2 Cr
Depreciation4 Cr4 Cr5 Cr5 Cr5 Cr5 Cr5 Cr6 Cr6 Cr6 Cr6 Cr7 Cr
Profit before tax4 Cr3 Cr5 Cr5 Cr5 Cr5 Cr6 Cr5 Cr5 Cr11 Cr18 Cr15 Cr
Tax %12.4%30.9%34.9%48.7%6.2%17.2%7.6%13.3%15.3%6.4%39.0%29.5%
Net profit4 Cr2 Cr3 Cr2 Cr5 Cr5 Cr6 Cr5 Cr5 Cr10 Cr11 Cr10 Cr
EPS (₹)₹1.68₹0.98₹1.46₹1.10₹2.17₹2.08₹2.66₹2.11₹2.03₹4.59₹4.96₹4.62

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales95 Cr128 Cr133 Cr153 Cr178 Cr252 CrSign in for TTM
Operating expenses (approx.)72 Cr99 Cr100 Cr115 Cr128 Cr183 CrSign in for TTM
EBITDA23 Cr29 Cr33 Cr38 Cr50 Cr69 CrSign in for TTM
OPM %23.9%22.9%24.9%25.0%28.0%27.4%Sign in for TTM
Other income1 Cr2 Cr5 Cr3 Cr1 Cr2 CrSign in for TTM
Interest2 Cr3 Cr6 Cr8 Cr9 Cr8 CrSign in for TTM
Depreciation8 Cr10 Cr15 Cr18 Cr21 Cr24 CrSign in for TTM
Profit before tax13 Cr19 Cr17 Cr16 Cr22 Cr40 CrSign in for TTM
Tax %19.3%19.8%24.4%26.6%18.7%23.3%Sign in for TTM
Net profit11 Cr15 Cr13 Cr12 Cr18 Cr30 CrSign in for TTM
EPS (₹)₹6.87₹8.73₹6.59₹5.64₹7.97₹13.70Sign in for TTM
Dividend payout %—0.0%0.0%0.0%0.0%0.0%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital16 Cr17 Cr19 Cr22 Cr22 Cr22 Cr
Reserves83 Cr110 Cr154 Cr241 Cr264 Cr302 Cr
Borrowings——111 Cr69 Cr75 Cr55 Cr
Other liabilities——52 Cr57 Cr55 Cr101 Cr
Total liabilities——336 Cr389 Cr415 Cr481 Cr
Fixed assets (net)——267 Cr313 Cr304 Cr319 Cr
CWIP——6 Cr0.32 Cr17 Cr4 Cr
Investments——3 Cr0 Cr0 Cr50 Cr
Inventories——15 Cr28 Cr44 Cr70 Cr
Trade receivables——22 Cr21 Cr31 Cr0 Cr
Cash & bank——0.09 Cr0.26 Cr0.10 Cr0.04 Cr
Other assets——22 Cr27 Cr20 Cr38 Cr
Total assets——336 Cr389 Cr415 Cr481 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity—36 Cr33 Cr24 Cr36 Cr49 Cr
Cash from investing—-90 Cr-74 Cr-52 Cr-32 Cr-28 Cr
Cash from financing—55 Cr41 Cr27 Cr-3 Cr-21 Cr
Net cash flow—-0.05 Cr0.06 Cr0.37 Cr-0.16 Cr-0.05 Cr
Free cash flow (OCF − Capex)—-62 Cr-49 Cr-35 Cr3 Cr49 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %16.0%17.1%8.0%7.1%8.3%12.5%
ROE %10.9%11.7%7.4%4.4%6.1%9.4%
Debtor days——6050630
Inventory days——76119166192
Days payable——12811880141
Cash conversion cycle——85114951
Debt / equity——0.640.260.260.17
Current ratio——1.031.211.401.28
Net debt / EBITDA0.000.003.351.791.510.80